BIOMAT Database Logo BIOMAT Database Logo

'NESTROFT'--an effective screening test for beta thalassemia trait. 1997

M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Department of Pediatrics, L.T.M.M. College, Sion, Mumbai.

OBJECTIVE To evaluate the efficacy of NESTROFT (Naked Eye Single Tube Red Cell Osmotic Fragility Test) as a screening tool for detection of beta thalassemia trait. METHODS Prospective study. METHODS Field camps in various parts of Gujarat and Maharashtra States. METHODS A total of 2525 subjects were screened. NESTROFT, complete hemogram including red cell indices and calculation of Mentzer's Fraction (MF) and discriminant functions (DF1-4) were done in all subjects. HbA2 was performed in 830 initial subjects to compute sensitivity, specificity and predictive values for various parameters. RESULTS NESTROFT (sensitivity 94.4%), as a single screening parameter was superior to any of the other evaluated parameters individually, besides being cost effective. Mean corpuscular volume (MCV) < 80 fl followed NESTROFT closely (sensitivity 93.7; p > 0.05). MCV < 75 fl had a significantly (p < 0.001) lower sensitivity (87.3%) in comparison to both of these parameters. In contrast, MF, DF1, DF2, DF3 and DF4 did not meet the requirements of a good screening test with sensitivity values of 66.2%, 54.9%, 47.2%, 64.1% and 55.6%, respectively. NESTROFT in combination with MCV < 80 fl proved 100% sensitive. However, the combination was not cost effective. CONCLUSIONS NESTROFT is a sensitive, cost effective, rapid and reliable screening test for detection of beta thalassemia trait in a population.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009996 Osmotic Fragility RED BLOOD CELL sensitivity to change in OSMOTIC PRESSURE. When exposed to a hypotonic concentration of sodium in a solution, red cells take in more water, swell until the capacity of the cell membrane is exceeded, and burst. Saline Fragility,Fragility, Osmotic,Fragility, Saline
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
NESTROFT: a screening test for beta thalassemia trait.
November 2002, Indian journal of medical sciences,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Nestroft screening tool for beta-thalassemia trait.
September 1996, Indian pediatrics,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
NESTROFT - A Valuable, Cost Effective Screening Test for Beta Thalassemia Trait in North Indian Punjabi Population.
December 2013, Journal of clinical and diagnostic research : JCDR,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Validity of Nestroft in screening and diagnosis of beta-thalassemia trait.
December 1997, Journal of tropical pediatrics,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Is NESTROFT sufficient for mass screening for beta-thalassaemia trait?
January 2007, Journal of medical screening,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
August 2006, Hematology (Amsterdam, Netherlands),
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
NESTROFF as a screening test for detection of Beta-thalassemia trait.
July 2002, Indian journal of pathology & microbiology,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy.
September 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Discriminant Indices for Screening Beta Thalassemia Trait: An Illusion of Choice.
April 2021, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
M Manglani, and M R Lokeshwar, and V G Vani, and N Bhatia, and V Mhaskar
Discrimination indices as screening tests for beta-thalassemia trait.
January 2008, Annals of hematology,
Copied contents to your clipboard!